E
Elixirpharmatech
–/10Traction
Elixapharmatech develops novel small molecule drugs to suppress immuno-inflammation. Their focus is on creating targeted therapies that modulate immune responses to treat inflammatory diseases.
HQ unknown
- Biotechnology
Updated 4 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Elixapharmatech develops novel small molecule drugs to suppress immuno-inflammation. Their focus is on creating targeted therapies that modulate immune responses to treat inflammatory diseases.